Alexandra S. Denniston

Alexandra Denniston is a partner in the firm’s Business Law Department. Ms. Denniston advises a wide variety of clients, including both public and private companies, with respect to the employee benefit and compensation aspects of mergers and acquisitions, initial public offerings and other corporate transactions. Ms. Denniston regularly advises public company clients on SEC reporting requirements related to executive compensation.  In addition, she represents employers and executives in the negotiation, design and implementation of employment, severance and change in control arrangements and equity and other incentive compensation plans and arrangements. 

Ms. Denniston also has experience advising clients on Title I of ERISA, including fiduciary, investment and prohibited transaction matters as well as counseling investment managers and investment funds regarding the establishment and operation of collective investment funds, venture capital operating companies and real estate operating companies.

Public Offerings

• Advising companies such as Rubius Therapeutics, Fleetmatics, Mimecast, bluebird bio, Neos Therapeutics, Jounce Therapeutics and Opower and investment banks such as Goldman Sachs and Morgan Stanley on executive compensation disclosure requirements

M&A – Executive Compensation

• Qualtrics International Inc. in its $8 billion sale to SAP SE
• Keryx Biopharmaceuticals, Inc. in connection with its merger with Akebia Therapeutics, Inc.
• Foundation Medicine, Inc. in connection with its merger with Roche at an enterprise valuation of $5.3 billion
• Juniper Pharmaceuticals in its sale to Catalent
• Fleetmatics in its $2.4 billion sale to Verizon
• Lionbridge in its sale to HIG
• Opower in its sale to Oracle
• Ocata Therapeutics in its sale to Astellas Pharma
• Onyx Pharmaceuticals in its $10 billion sale to Amgen
• Fleetmatics in its acquisition of SageQuest

Ongoing Public Company Representation

• iRobot, Wayfair, Rubius Therapeutics, Mimecast, bluebird bio, Brightcove, GTT Communications, WisdomTree Investments, Assembly Biosciences, Viveve, Cedar Realty Trust, Empire State Realty Trust, Medical Properties Trust